The successful use of electroconvulsive therapy in a patient with interferon-induced psychotic depression

被引：6
作者：
Zincke, Miriam Tanja [1 ]
Kurani, Amit [1 ]
Istafanous, Rafik [1 ]
Kellner, Charles [1 ]
机构：
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA
来源：
JOURNAL OF ECT | 2007年 / 23卷 / 04期
关键词：
ECT; pegylated interferon alfa-2b; HCV;
D O I：
10.1097/YCT.0b013e3181492224
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
We report the successful use of electroconvulsive therapy in a patient who developed major depression with psychotic features while being treated with interferon alfa-2b for hepatitis C. We reviewed the literature of similar cases and discuss treatment options for interferon-induced depression and psychosis.
引用
收藏
页码：291 / 292
页数：2
相关论文
共 13 条
  • [1] Interferon-induced depression in chronic hepatitis C: A review of its prevalence, risk factors, biology, and treatment approaches
    Asnis, GM
    De La Garza, R
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (04) : 322 - 335
  • [2] Interferon-induced depression: Strategies in treatment
    Asnis, GM
    De La Garza, R
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (05) : 808 - 818
  • [3] Review article: the management of side-effects during therapy for hepatitis C
    Aspinall, RJ
    Pockros, PJ
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (09) : 917 - 929
  • [4] Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state
    Capuron, L
    Ravaud, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (17) : 1370 - 1370
  • [5] Crone Catherine, 2003, J Psychiatr Pract, V9, P93, DOI 10.1097/00131746-200303000-00002
  • [6] A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon
    Fattovich, G
    Giustina, G
    Favarato, S
    Ruol, A
    Macarri, G
    Orlandi, F
    Iaquinto, G
    Ambrosone, L
    Francavilla, A
    Pastore, G
    Santantonio, MT
    Romagno, D
    Bolondi, L
    Sofia, S
    Marchesini, A
    Pisi, E
    Mazzella, G
    Roda, E
    Attaro, L
    Chiodo, F
    Mori, F
    Verucchi, G
    Lanzini, A
    Salmi, A
    Calvi, B
    Bozzetti, F
    Radaeli, E
    Bernasconi, M
    Pilleri, G
    Bacca, D
    Romano, G
    Mastrapasqua, G
    Cozzolongo, R
    Cacopardo, B
    Nunnari, A
    Blasi, A
    Sala, LO
    Minoli, G
    Sangiovanni, A
    Spinzi, GC
    Colombo, A
    Camassa, M
    Riva, D
    Maggi, G
    Boccia, S
    Gualandi, G
    Nucci, A
    Pacini, F
    Marino, N
    Mazzotta, F
    [J]. JOURNAL OF HEPATOLOGY, 1996, 24 (01) : 38 - 47
  • [7] A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C
    Hauser, P
    Khosla, J
    Aurora, H
    Laurin, J
    Kling, MA
    Hill, J
    Gulati, M
    Thornton, AJ
    Schultz, RL
    Valentine, AD
    Meyers, CA
    Howell, CD
    [J]. MOLECULAR PSYCHIATRY, 2002, 7 (09) : 942 - 947
  • [8] Chronic hepatitis C, depression and interferon
    Horsmans, Y
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 (06) : 788 - 789
  • [9] Paroxetine for the prevention of depression induced by high-dose interferon alfa
    Musselman, DL
    Lawson, DH
    Gumnick, JF
    Manatunga, AK
    Penna, S
    Goodkin, RS
    Greiner, K
    Nemeroff, CB
    Miller, AH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (13) : 961 - 966
  • [10] Neuropsychiatric complications associated with interferon-alpha-2b treatment of malignant melanoma
    Okereke, OI
    [J]. PSYCHOSOMATICS, 2002, 43 (03) : 237 - 240
12